Speaker List 2017 Pegs Summit

2017 Archived Content

OVERVIEW | DOWNLOAD BROCHURE | SPEAKERS | SHORT COURSES

PEGS 2017 Speakers

Plenary Keynote Speakers:

Sir Gregory Winter, Ph.D., FRS, Master, Trinity College and Co-Founder and Director, Bicycle Therapeutics
Tim Whitehead, Ph.D., Assistant Professor, Chemical Engineering and Materials Science, Michigan State University

Distinguished Faculty:

Chloé Ackaert, Ph.D., Post-Doctoral Researcher, Bioengineering Sciences, Camel Antibodies Lab, Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB)
Prasad S. Adusumilli, M.D., F.A.C.S., Associate Attending and Deputy Chief, Thoracic Surgery, Memorial Sloan Kettering Cancer Center
Mahiuddin Ahmed, Ph.D., Assistant Attending, Immunotherapies, Pediatrics, Memorial Sloan Kettering Cancer Center
Steven Almo, Ph.D., Chairman, Biochemistry, and Professor, Biochemistry and Physiology & Biophysics, Montefiore Medical Center, Albert Einstein College of Medicine
Frederick Alt, Ph.D., Charles A. Janeway Professor of Pediatrics, Boston Children’s Hospital; Professor of Genetics, Harvard Medical School; Director, Program in Cellular and Molecular Medicine, Boston Children’s Hospital
Galit Alter, Ph.D., Associate Professor, Medicine; Kristine & Bob Higgins MGH Research Scholar; Director, Ragon Institute Imaging Core; Director, Harvard Center for Aids Research Immunology Core
Luis Alvarez-Vallina, Ph.D., Associate Professor, Engineering, Aarhus University
Zhiqiang An, Ph.D., Professor and Robert A. Welch Distinguished University Chair in Chemistry, University of Texas Health Science Center at Houston
Juni Andréll, Ph.D., Researcher, Biochemistry and Biophysics, University of Stockholm
Christian Antoni, Ph.D., Vice President, Immunology & Inflammation, Sanofi
Philip M. Arlen, M.D., President and CEO, Precision Biologics, Inc.
Gai Ayalon, Ph.D., Scientist, Neuroscience, Genentech
John Babcook, Ph.D., Senior Vice President, Discovery Research, Zymeworks Inc.
Sashikanth Banappagari, Ph.D., Scientist, Formulation Development, Vaccine Research Center, National Institutes of Health
Robin Barbour, Head, Antibody and Assay Development, Research, Prothena Biosciences
Ishan Barman, Ph.D., Assistant Professor, Mechanical Engineering, Johns Hopkins University
Amrik Basran, CSO, Therapeutics, Avacta Life Sciences
Nicola Beaucamp, Ph.D., Head, Process Research, Pharma Research and Early Development, Roche Innovation Center
Paul Beavis, Ph.D., Senior Postdoctoral Researcher, Cancer Immunotherapy, Peter MacCallum Cancer Centre
Roger R. Beerli, Ph.D., CSO, NBE-Therapeutics AG
Donald A. Bergstrom, M.D., Ph.D., CMO, Mersana Therapeutics
Alison Betts, Ph.D., Associate Research Fellow, Biomedicine Design, Pfizer
Michael J. Betenbaugh, Ph.D., Department of Chemical and Biomolecular Engineering, Johns Hopkins University
Rudi Beyaert, Ph.D., Vice Department Director, Inflammation Research Center, VIB
Tuhin Bhowmik, Ph.D., Scientist I, Formulation, Takeda Vaccines
Carl Uli Bialucha, Ph.D., Director, Oncology Biotherapeutics, Novartis Institutes for Biomedical Research, Inc.
Murali Bilikallahalli, Ph.D., Senior Director, Ultragenyx Pharmaceuticals
John W. Blankenship, Ph.D., Lead Scientist, Molecular Biology & Protein Engineering, Aptevo Therapeutics
Adrian Bot, M.D., Ph.D., Vice President, Translational Medicine, Kite Pharma
George Bou-Assaf, Ph.D., Scientist, Technical Development, Biogen
Andrew M. Bradbury, M.D., Ph.D., Staff Scientist, Biosciences, Los Alamos National Laboratory
Dennis Breitspecher, Ph.D., Head of Research and Development – Biochemistry, NanoTemper Technologies, GmbH
John S. Bridgeman, Ph.D., Director of Cell Therapy Research, Cellular Therapeutics, Ltd.
Lisa Burdette, Laboratory for the Engineering of Membrane Proteins and Protein Membranes, Department of Chemical and Biomolecular Engineering, Northwestern University
Marco Cacciuttolo, Ph.D., Project Office, Batavia Biosciences
Nico Callewaert, Ph.D., Director, VIB Medical Biotechnology Center, Ghent University
Julio A. Camarero, Ph.D., Associate Professor, Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California
Uwe Carl, Ph.D., Head, Protein Production, Strep-Tag Products and Proteins, IBA Lifesciences
Ralf Joe Carrillo, Ph.D., Senior Scientist, Physical Chemistry, AbbVie
Jennifer Cha, Ph.D., Norviel Associate Professor, Chemical & Biological Engineering, University of Colorado, Boulder
Kartik Chandran, Ph.D., Professor, Microbiology and Immunology, Harold and Muriel Block Faculty Scholar in Virology, Albert Einstein College of Medicine
Smita Chandran, Ph.D., Senior Research Scientist, Memorial Sloan Kettering Cancer Center
Paul B. Chapman, M.D., Medical Oncologist, Memorial Sloan Kettering Cancer Center
Ravi Chari, Ph.D., Vice President, Chemistry & Biochemistry, ImmunoGen, Inc.
Nai-Kong V. Cheung, M.D., Ph.D., Enid A. Haupt Chair, Pediatric Oncology, Memorial Sloan Kettering Cancer Center
Aaron Chevalier, Ph.D., CSO, Virvio, Inc.; Translational Investigator, Institute of Protein Design, University of Washington
Yite Robert Chou, Ph.D., Principal Scientist, Merck
Vijay Chudasama, Ph.D., Lecturer, Organic Chemistry and Chemical Biology, University College London
Steven Coats, Ph.D., Vice President, R&D, MedImmune
Jennifer Cochran, Ph.D., Hitachi America Associate Professor, Bioengineering and Chemical Engineering, Stanford University
Luis G. Cuello, Ph.D., Associate Professor, Cell Physiology and Molecular Biophysics and Center for Membrane Protein Research, Texas Tech University Health Sciences Center
Michael A. Curran, Ph.D., Assistant Professor, Immunology, MD Anderson Cancer Center
Brendan Curti, Director, Genitourinary Oncology Research, Immunotherapy Clinical Program, Providence Medical Group
Charles S. Craik, Ph.D., Professor, Pharmaceutical Chemistry, University of California, San Francisco
Steven Cramer, Ph.D., Professor, Rensselaer Polytechnic Institute
James E. Crowe, Jr., M.D., Professor, Pathology, Microbiology & Immunology, Vanderbilt University
Niklas Czeloth, Ph.D., Head, Biosciences, Biosimilars, Boehringer Ingelheim GmbH
Jostein Dahle, Ph.D., CSO, Nordic Nanovector ASAc
Paul Dalby, Ph.D., Professor of Biochemical Engineering and Biotechnology, University College London
Amita Datta-Mannan, Ph.D., Research Advisor and Group Leader, Eli Lilly and Company
Patrick S. Daugherty, Ph.D., President & CSO, Serimmune Inc.; Adjunct Professor, University of California, Santa Barbara
Marco Davila, M.D., Ph.D., Associate Member, Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute
Jonathan H. Davis, Ph.D., Principal Scientist, Protein Design, Bristol-Myers Squibb
Tom Davis, M.D., Executive Vice President and CMO, Celldex Therapeutics Inc.
Jeremy Derrick, Ph.D., Professor, Molecular Microbiology, University of Manchester
John R. Desjarlais, Ph.D., CSO, Xencor, Inc.
Adi Diab, M.D., Assistant Professor, MD Anderson Cancer Center
Rakesh Dixit, Ph.D., DABT, Vice President, R&D, Global Head, Biologics Safety Assessment, Translational Sciences, MedImmune
Bart De Goeij, Scientist, Antibody Science, GenMab A.V.
Gael Debauve, Ph.D., Associate Director, Bioassays, UCB
Cesar de la Fuente, Ph.D., Postdoctoral Associate, Biological Engineering, MIT/Broad Institute of MIT and Harvard
Julio Delgado, MD, Medical Director and Section Chief, Immunology Division, ARUP Laboratories; Associate Professor, Pathology, University of Utah School of Medicine
Stephen J. Demarest, Ph.D., Senior Research Advisor, Protein and Antibody Engineering, Lilly Biotechnology Center
Ratmir Derda, Ph.D., Assistant Professor, Chemistry, University of Alberta
John Desjarlais, Ph.D., CSO, Xencor
Craig D. Dickinson, Ph.D., Senior Research Advisor, AME, Eli Lilly and Company
Anaëlle Dos Santos, Ph.D., Head, Bioanalytical Development, NovImmune
Jonathan Drachman, M.D., CMO and Executive Vice President, Research and Development, Seattle Genetics
Keren Drori, Ph.D., Product Manager II, Protein Science, Takara Bio USA
Zhimei Du, Ph.D., Senior Principal Scientist, Merck & Company, Inc.
Jakob Dupont, Ph.D., Senior Vice President, Oncomed Pharmaceutical
Scott J. Dylla, Ph.D., Vice President, Research & Development, CSO, AbbVie Stemcentrx, LLC
Michael Dyson, Ph.D., CTO, IONTAS, Ltd.
Aris N. Economides, Ph.D., Executive Director; Genome Engineering Technologies, and Skeletal Diseases TFA, Co-Founder & Head of Functional Modeling; Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc.
Sabine Eichling, Senior Scientist, Abbvie
Sam Ellis, Vice President & Biochemist, Thomson Instrument Company
Peter Ellmark, Ph.D., Principal Scientist, Research & Development, Alligator Bioscience
Peter Emtage, Ph.D., CSO, Cell Design Labs
Elizabeth England, Scientist, Antibody Discovery and Protein Engineering, MedImmune
James A. Ernst, Ph.D., Senior Scientist, gRED, Protein Chemistry and Neuroscience, Research and Early Development, Genentech, Inc.
Seth Ettenberg, Ph.D., CSO, Unum Therapeutics
Rachel Ettinger, Ph.D. Senior Scientist Respiratory, Inflammatory, and Autoimmune Diseases, MedImmune
David Gilham, Ph.D., Vice President, Research & Development, Celyad S.A.
Soldano Ferrone, M.D., Ph.D., Division of Surgical Oncology, Surgery, Massachusetts General Hospital
Dina Finan, Ph.D., Product Manager, Unchained Labs
Mark T. Fisher, Ph.D., Professor, Biochemistry and Molecular Biology, University of Kansas Medical School
Fredrik Frejd, Ph.D., CSO, Affibody AB
Matthew J. Frigault, M.D., Clinical Fellow in Medicine, Dana-Farber Cancer Institute
Yang-Xin Fu, M.D., Ph.D., Mary Nell and Ralph B. Rogers Professorship in Immunology, University of Texas, Southwestern Medical Center
Jim Freeth, Managing Director, Retrogenix Limited
Ricarda Friebe, MSc, Scientific Assistant, Institute of Bioprocess Engineering, Friedrich-Alexander-University Erlangen-Nürnberg
Anja Fritsch, Ph.D., CSO, Solvias
Terry J. Fry, M.D., Investigator and Head, Hematologic Malignancies Section, Pediatric Oncology Branch, National Cancer Institute
Gayatri Ganeshan, Scientist, Biologics and Vaccines, Merck
Robert F. Garry, Ph.D., Professor, Microbiology & Immunology, Tulane Medical School; Co-Founder, Zalgen Labs
John Garza, Ph.D., Development Scientist II, Analytical Sciences, Alexion Pharmaceuticals
Kurt Gehlsen, Ph.D., Vice President and CSO, Therapeutics, Research Corporation Technologies, Inc.
Tariq Ghayur, Ph.D., Distinguished Research Fellow, Biologics, AbbVie Bioresearch Center, Inc.
Maloy Ghosh, Ph.D., CSO, Zumutor Biologics
Pierre-Alain Girod, Ph.D., CSO, Selexis
Shalom Goldberg, Ph.D., Senior Scientist, Johnson & Johnson
Theresa J. Goletz, Ph.D., Global Head, NBE Drug Disposition, QPD, EMD Serono
Ulrich Göpfert, Ph.D., Principal Scientist, Cell Line & Molecular Development, Roche Innovation Center
Sean Gray, Ph.D., Senior Scientist, PAI Life Sciences
Karl E. Griswold, Ph.D., Associate Professor, Thayer School of Engineering, Dartmouth
Jijie Gu, Ph.D. Research Fellow, Immunology & Oncology Biologics at Global Biologics, AbbVie
Chandrasekhar Gurramkonda, Ph.D., Research Assistant Professor, Chemical, Biochemical and Environmental Engineering, University of Maryland
Andrew Hanneman, Associate Director, Mass Spectrometry, Charles River
Haruki Hasegawa, Ph.D., Principal Scientist, Therapeutic Discovery, Amgen, Inc.
Ronald Herbst, Ph.D., Vice President and Head, Oncology Research, MedImmune
Guy Hermans, CSO, Isogenica Limited
John Hickey, Ph.D., Assistant Director, Macromolecule and Vaccine Stabilization Center, University of Kansas
Oliver Hill, Ph.D., Vice President, Molecular Biology, APOGENIX AG
Mitchell Ho, Ph.D., Chief, Antibody Therapy Section, Laboratory of Molecular Biology, National Cancer Institute, NIH
Björn Hock, Ph.D., Senior Director, Global Head ADCs and Targeted NBE Therapeutics, Merck KGaA
Josefin-Beate Holz, Ph.D., Bioneer-Consulting, part of NDA
Axel Hoos, M.D., Ph.D., Senior Vice President, Therapeutic Area Head for Oncology R&D, GlaxoSmithKline Pharmaceuticals, Inc.
Walter Hoyer, Ph.D., Manager, Statistics, GSK Vaccines
John Hunt, Ph.D., Professor, Biological Sciences, Columbia University
David Humphreys, Ph.D., Director and Head, Protein Sciences, UCB NewMedicines
Rafiq Islam, Ph.D., Senior Director, Bioanalytical Services, Celerion, Inc.
Yoshi Itoh, Ph.D., Associate Professor and Principal Investigator, Cell Migration Group, Kennedy Institute of Rheumatology, University of Oxford
Bent Jakobsen, Ph.D., CSO, Immunocore Ltd.
Darshana Jani, Ph.D., Senior Manager, Global Assay Lead, Pfizer
Donald Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming
Jeliazko Jeliazkov, Research Assistant, Molecular Biophysics, Johns Hopkins University
Karin Jooss, Ph.D., CSO, Gritstone Oncology, Inc.
Sujith K Joseph, Ph.D., Staff Scientist, Department of Pediatrics Center for Cell and Gene Therapy Baylor College of Medicine
Vanessa Jully, Ph.D., Scientist, Research & Development, GlaxoSmithKline
Ravi C. Kalathur, Ph.D., New York Structural Biology Center, New York Consortium on Membrane Protein Structure (NYCOMPS)
Paul Kang, CSO, Discovery Research, Innovative Targeting Solutions
Guna Kannan, Ph.D., Director Antibody Engineering & CMC, Affinita Biotech
Raghuraman Kannan, Ph.D., Associate Professor, Radiology and Biological Engineering, School of Medicine, University of Missouri
Shefali Kakar, Ph.D., Executive Director, Head, Oncology, Clinical Pharmacology, Novartis
Azad Kaushik, DVM, D.Sc., Associate Professor, College of Biological Science, Department of Molecular and Cellular Biology, University of Guelph
Saad Kenderian, M.D., Assistant Professor of Medicine and Oncology, Hematology, Mayo Clinic College of Medicine
Randal Ketchem, Ph.D., Vice President, Molecular Design, Just Biotherapeutics
Hubert Kettenberger, Ph.D., Senior Principal Scientist, Protein Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Penzberg
Maura Kibbey, Ph.D., Director, Science & Standards, Global Biologics, United States Pharmacopeial Convention
Takanori Kigawa, Ph.D., Team Leader, Quantitative Biology Center (QBiC), RIKEN
Chava Kimchi-Sarfaty, Ph.D., Research Chemist, Principal Investigator, Division of Hematology Research and Review, FDA/CBER/OBRR
Christian Klein, Ph.D., Discovery Oncology oDTA, Pharma Research and Early Development (pRED), Roche Glycart AG
Hans Klingemann, M.D., Ph.D., Vice President, Research & Development, NantKwest, Inc.
David M. Knipe, Ph.D., Department of Microbiology and Immunobiology, Harvard Medical School
Emilee Knowlton, Ph.D., Immunology Sales Specialist, ProImmune
Shohei Koide, Ph.D., Professor, Biologics Design, Langone Medical Center, New York University
Natalia Kozhemyakina, Ph.D., Head, Bioassay Laboratory, Analytical Development Department, BIOCAD
Roland Kontermann, Ph.D., Professor of Biomedical Engineering, Institute of Cell Biology and Immunology, University of Stuttgart
Thomas Krey, Ph.D., Institute of Virology, Structural Virology Group, Hannover Medical School
Torsten Kuiper, Principal Scientist, BTDM Integrated Biologics Profiling, Novartis Pharma AG
Vinodh Kurella, Ph.D., Senior Scientist, Protein Engineering, ImmunoOncology Division, Intrexon Corporation
David Laidlaw, CEO, Kuhner Shaker, Inc.
Annie Lam, Ph.D., Scientist II, Antibody Engineering, MacroGenics, Inc.
John Lambert, Ph.D., Executive Vice President and Distinguished Research Fellow, ImmunoGen
Ramil Latypov, Ph.D., Associate Director, Research & Development, Sanofi Genzyme
Hans-Georg Lerchen, Ph.D., Principal Scientist, Drug Discovery, MedChem, Bayer AG
Cammie Lesser, M.D., Ph.D., d’Arbeloff MGH Research Scholar, Associate Professor, Medicine, Microbiology and Immunobiology, Massachusetts General Hospital/Harvard Medical School
Randolph P. Lewis, Ph.D., USTAR Professor, Biology / Synthetic Bio-Manufacturing, Utah State University
Raquel Lieberman, Ph.D., School of Chemistry & Biochemistry, Georgia Institute of Technology
Shihua Lin, Ph.D., Senior Scientist, Analytical Biotechnology Development, MedImmune LLC
Bin Liu, Ph.D., Professor, Anesthesia, University of California, San Francisco
Curtis Lockshin, Ph.D., Chief Scientific Officer, Xenetic Biosciences, Inc.
David Lowe, Ph.D., Director, R&D, Antibody Discovery and Protein Engineering, MedImmune Ltd.
Linlin Luo, Ph.D., Senior Research Investigator, BMS
Mark Ma, Ph.D., Senior Director, Bioanalytical Development, Alexion Pharmaceuticals
David G. Maloney, M.D., Ph.D., Medical Director, Cellular Immunotherapy; Leonard and Norma Klorfine Endowed Chair for Clinical Research, Fred Hutchinson Cancer Research Center; Professor, Medicine, Oncology, University of Washington
Tony Manning, Ph.D., Vice President, Research, Momenta Pharmaceuticals
Wayne Marasco, Professor, Cancer Immunology and Virology, Dana-Farber Cancer Institute
Paolo Marcatili, Ph.D., Assistant Professor, Bio and Health Informatics, Technical University of Denmark
Erminia Massarelli, M.D., Ph.D., MS, Associate Clinical Professor, Medical Oncology and Therapeutics Research, City of Hope
Paul Matsudaira, Ph.D., Professor, Dept. of Biological Sciences, National University of Singapore
Jon R. McDaniel, Ph.D., Georgiou Laboratory, Chemical Engineering, Biomedical Engineering, Molecular Biosciences; Institute for Cellular and Molecular Biology, University of Texas at Austin
Yvonne McGrath, Ph.D., CSO, Complix NV
J. Joseph Melenhorst, Ph.D., Director, Product Development & Correlative Sciences Laboratories (PDCS); Adjunct Associate Professor, Center for Cellular Immunotherapies, University of Pennsylvania
Tatyana Mezhebovsky, Ph.D., Principal Scientist, BioFormulations Development, Sanofi
Jennifer Michaelson, Ph.D., Executive Program Leader, Senior Director of Preclinical Development, Preclinical Development, Jounce Therapeutics Inc.
Jeffrey S. Miller, M.D., Professor, Medicine, Division of Hematology, Oncology and Transplantation; Deputy Director, Masonic Cancer Center, University of Minnesota
Stephen D. Miller, Ph.D., Professor, Microbiology-Immunology and Dermatology, Northwestern University
David Meininger, Chief Business Officer, Trianni, Inc.
Christoph Merten, Ph.D., Group Leader Microfluidics, European Molecular Biology Laboratory (EMBL)
Marissa Mock, Ph.D., Senior Scientist, Therapeutic Discovery; Biologics, Amgen
Joerg Moelleken, Ph.D., Senior Scientist, Roche Pharmaceutical Research and Early Development, Large Molecule Research, Roche Innovation
Ekkehard Moessner, Ph.D., Head, Protein Engineering, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich
Vera Molkenthin, Ph.D., Chief Scientist, AbCheck s.r.o.
Aaron Morris, Senior Director, Research, Checkmate Pharmaceuticals, Inc.
Barry A. Morse, Ph.D., Principal Research Scientist, Janssen Research and Development
Masaru Muraoka, Ph.D., Research Scientist, Chugai Pharmabody Research PTE. LTD.
Peter Neubauer, Ph.D., Professor, Bioprocess Engineering, Biotechnology, Technische Universität Berlin (TU Berlin)
Ahuva Nissim, Ph.D., Associate Professor, Antibody and Therapeutic Engineering, William Harvey Research Institute, Queen Mary University of London
Nili Ostrov, Ph.D., Research Fellow, Genetics, Harvard Medical School
Tadas Panavas, Ph.D., Associate Director, Discovery Research, Alexion Pharmaceuticals, Inc.
Peter Park, Ph.D., Vice President, Oncology Research, Bicycle Therapeutics
Edward F. Patz, Jr., M.D., James and Alice Chen Professor, Radiology; Professor, Pharmacology and Cancer Biology, Radiology, Duke University Medical Center
Bradley L. Pentelute, Ph.D., Professor, Chemistry, Massachusetts Institute of Technology
Juergen M. Plitzko, Ph.D., Head, TEM, Molecular Structural Biology, Max Planck Institute of Biochemistry
Horacio G. Nastri, Ph.D., Senior Director, Antibody Biotherapeutics, Incyte Corporation
Dario Neri, Ph.D., Professor, Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), and Co-Founder, Philogen
Vincent Noireaux, Ph.D., School of Physics and Astronomy, University of Minnesota
Natko Nuber, Ph.D., Laboratory Head, BTDM-BPD, Novartis Biologics R&D, Novartis
Michael Oropallo, Ph.D., Associate Scientist, Postdoctoral Fellow, Safety Assessment & Laboratory Animal Resources, Merck
Andreas Pahl, Ph.D., CSO, Heidelberg Pharma
Michelle Palmer, Ph.D., Director, Bioanalytical Science, ImmunoGen
Rajita Pappu, Ph.D., Senior Scientist, Genentech
Belinda Pastrana, Ph.D., Professor, Chemistry, University of Puerto Rico Mayaguez, Puerto Rico
James Patterson, Ph.D., Senior Scientist, Project Leader, Antibody Technologies and Chemical Biology, Sorrento Therapeutics, Inc.
Pedro Paz., Ph.D., BR US Lead Discovery, Immunoassay/Immunoprofiling Group, Bayer HealthCare
David Pearlman, Senior Principal Scientist, Schrödinger
Josh T. Pearson, Ph.D., Principal Scientist, Pharmacokinetics & Drug Metabolism, Amgen
Bradley L. Pentelute, Ph.D., Pfizer Laubach Career Development Assistant Professor, Chemistry, Massachusetts Institute of Technology
Michael Postow, M.D., Medical Oncologist, Department of Medicine, Memorial Sloan Kettering Cancer Center
Kathleen Pratt, Ph.D., Associate Professor, Department of Medicine, Uniformed Services University
Ming Proschitsky, Ph.D., Senior Scientist, Research, Proclara Biosciences
James R. Prudent, Ph.D., President & CEO, Centrose
Yan Qu, Ph.D., Senior Principal Scientist, Pfizer
Isam Qahwash, Ph.D., Manager, Bioassay Development, Molecular and Analytical Development, Bristol-Myers Squibb
Christophe Quéva, Ph.D., CSO, iTeos Therapeutics SA
Francisco Quintana, Ph.D. Associate Scientist, Brigham and Women’s Hospital; Associate Professor, Neurology, Harvard Medical School
Anacelia Ríos Quiroz, Ph.D., Group Leader, Particle Lab, Pharma Technical Development Europe (Biologics) Analytics, F. Hoffmann-La Roche Ltd.
Christoph Rader, Ph.D., Associate Professor, Immunology, The Scripps Research Institute
Laszlo Radvanyi, Ph.D., Senior Vice President and Global Head of The Immuno-Oncology Translational Innovation Platform at EMD Serono (a business of Merck KGaA, Darmstadt, Germany)
Reema Raghavendra, Scientist, AbbVie
Miki Rahat, D.Sc., Assistant Professor, Immunology, Technion; Director, Research Laboratories, Carmel Medical Center
G. Jonah Rainey, Ph.D., Senior Scientist, ADPE, MedImmune, LLC
Sai Reddy, Ph.D., Assistant Professor, Biosystems Science and Engineering, ETH Zurich
Joerg Regula, Ph.D., Head of Functional Characterization, Roche
Janice M. Reichert, Ph.D., Executive Director, The Antibody Society and Editor-in-Chief, mAbs
Ed Reilly, Ph.D., Senior Research Fellow, Oncology Discovery, AbbVie
Yoram Reiter, Ph.D., Professor & Head, Laboratory of Molecular Immunology, Technion-Israel Institute of Technology
Sarah Richman, M.D., Ph.D., Instructor, Cancer Center, The Children’s Hospital of Philadelphia
Christopher J. Roberts, Ph.D., Professor, Chemical & Biomolecular Engineering, University of Delaware
Johan Rockberg, Ph.D., Assistant Professor, Proteomics and Nanobiotechnology, KTH - Royal Institute of Technology
Christine Rothe, Ph.D., Vice President, Discovery & Alliance Management, Pieris Pharmaceuticals GmbH
Michael Rosenzweig, Ph.D., Executive Director, Oncology Discovery, Merck Research Labs
Sharon Rosovsky, Ph.D., Assistant Professor, Chemistry and Biochemistry, University of Delaware
Gargi Roy, Ph.D., Scientist, MedImmune
Kris F. Sachsenmeier, Ph.D., Associate Director, Translational Sciences, AstraZeneca
Jason Sagert, Ph.D., Senior Scientist II, Oncology, CytomX Therapeutics
Mika Sakurai, Ph.D., Biologics Discovery Dept., Chugai Pharmaceutical Co., Ltd.
Hardeep Samra, Ph.D., Senior Scientist, Formulation Sciences, MedImmune
Thomas Sandal, Ph.D., Vice President, Preclinical Development and Protein Engineering, Crescendo Biologics Ltd.
Puja Sapra, Ph.D., Vice President and CSO, Target Therapeutics Unit, Oncology Research & Development, Pfizer, Inc.
David Satijn, Ph.D., Director, New Antibody Products, Genmab
Jeffrey G. Saven, Ph.D., Professor, Chemistry, University of Pennsylvania
Guido Seidel, Managing Director, Operations, Wacker Biotech GmbH
Kathy Seidl, Ph.D., Director, Immunotherapy, bluebird bio
Oliver Seifert, Ph.D., Post-Doc, Institute of Cell Biology and Immunology, University of Stuttgart
Saurabh Sen, Ph.D., Principal Scientist, Boehringer Ingelheim Pharmaceuticals, Inc.
Dolores Schendel, Ph.D., CEO and CSO, Medigene AG
Peggy Scherle, Ph.D., Vice President, Preclinical Pharmacology, Incyte Corporation
Justin M. Scheer, Ph.D., Director, Antibody Engineering, Boehringer Ingelheim Pharmaceuticals, Inc.
Volker Schellenberger, Ph.D., President and CEO, Amunix
Stefan Schmidt, Ph.D., M.B.A., Vice President, Process Science and Production, Rentschler Biotechnology
Jonathan Schneck, M.D., Ph.D., Professor, Pathology Medicine and Oncology, Johns Hopkins University
W. Mike Schopperle, Ph.D., CEO, CureMeta LLC
Taylor Schreiber, M.D., Ph.D., Scientific Founder, R&D, Shattuck Labs, Inc.
Charles Sentman, Ph.D., Director, Center for Synthetic Immunity, The Geisel School of Medicine, Dartmouth College
Andrew Sewell, Ph.D., Distinguished Research Professor and Wellcome Trust Senior Investigator, Cardiff University School of Medicine
Lu Shan, Ph.D., Scientist II, Antibody Discovery & Protein Engineering, MedImmune/AstraZeneca
Whitney Shatz, MS, Senior Scientific Researcher, Genentech
Anthony Shock, Ph.D., Director, Immunology Portfolio, UCB
Harpreet Singh, Ph.D., President & CEO, Immatics US, Inc.
Arne Skerra, Ph.D., Professor, Technische Universität Munich; and and Chairman & Founder, XL-protein GmbH
Matthew Sleeman, Ph.D., Executive Director, Immunology & Inflammation, Regeneron Pharmaceuticals, Inc.
Eric Smith, Ph.D., Associate Director, Bispecifics, Regeneron Pharmaceuticals
Ernest S. Smith, Ph.D., Senior Vice President, Research & Chief Scientific Officer, Vaccinex, Inc.
Oliver Spadiut, Ph.D., Principal Investigator, Biochemical Engineering, Vienna University of Technology
Julian Spallholz, Ph.D., Professor, Nutritional Biochemistry, Nutritional Sciences, Texas Tech University
Jamie Spangler, Ph.D., Postdoctoral Fellow, Garcia Lab, Molecular & Cellular Physiology and Structural Biology, Stanford University School of Medicine
Dirk Spitzer, Ph.D., Assistant Professor, Surgery, Washington University School of Medicine
Tom Spitznagel, Ph.D., Senior Vice President, BioPharmaceutical Development and Manufacturing, MacroGenics, Inc.
Priya Sriraman, Ph.D., Principal Investigator, Non-Clinical Safety, Celgene
Abhishek Srivastava, Ph.D., Fellow, Surgery Branch, National Cancer Institute, NIH
Ammar Sukari, M.D., Assistant Professor, Head and Neck Multi-Disciplinary Team Leader, Department of Oncology, School of Medicine , Wayne State University/Karmanos Cancer Institute
Shantanu Sule, Ph.D., Senior Research Scientist, Eli Lilly & Company
Ying Sun, Ph.D., Associate Director of Chemistry, Ambrx
Rajasekhar Suragani, Ph.D., Associate Director, Acceleron Pharma, Inc.
Michael Szardenings, Ph.D., Group Head, Ligand Development, Fraunhofer Institute for Cell Therapy and Immunology
David Teachey, M.D., Associate Professor, Pediatrics, Children’s Hospital of Philadelphia
Srivalli Telikepalli, Ph.D., Research Chemist, National Institute of Standards and Technology
Peter M. Tessier, Ph.D., Richard Baruch M.D. Career Development Professor, Chemical & Biological Engineering, Rensselaer Polytechnic Institute
Christopher D. Thanos, Ph.D., Senior Director, Biotherapeutics Discovery, Halozyme Therapeutics
Nels Thorsteinson, Scientific Services Manager, Biologics, Chemical Computing Group
Stella Tournaviti, Ph.D., Senior Scientist, Cell Line and Molecular Development, Roche Innovation Center
Michael Townsend, Ph.D., Associate Director, Biomarker Discovery OMNI, Genentech
Miller Tran, Ph.D., Senior Scientist, Lead Discovery, Verdant Therapeutics, Inc.
Martin Treder, Ph.D., CSO, Affimed, NV.
Elizabeth M. Topp, Ph.D., Dane O. Kildsig Chair and Department Head, Department of Industrial and Physical Pharmacy, Perdue University
Michael Tovey, Ph.D., INSERM Director, Research, Laboratory of Biotechnology & Applied Pharmacology, Ecole Normale Supérieure de Cachan
Stella Tournaviti, Ph.D., Senior Scientist, Cell Line and Molecular Development, Roche Innovation Center
Corinne Ueberschlag, M.Sc., Fellow, Functional Lead Cell Line Development, Biologics Technical Development and Manufacturing, Novartis AG
Michiel E. Ultee, Ph.D., Principal, Ulteemit BioConsulting, LLC
Inna Vainshtein, Ph.D., Principal Scientist, Clinical Pharmacology & DMP, MedImmune LLC
Bahram (Bob) Valamehr, Ph.D., MBA, Vice President, Cancer Immunotherapy, Fate Therapeutics Inc.
Thomas J. Van Blarcom, Ph.D., Associate Research Fellow, Rinat Laboratories, Bio-Therapeutics Division, Pfizer Inc.
Neal Van Hoeven, Ph.D., Senior Scientist, Infectious Disease Research Institute
Niels Vande Casteele, Pharm.D., Ph.D., Postdoctoral Fellow, Gastroenterology, University of California, San Diego
Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Annelise Vuidepot, Ph.D., Head, Protein Science, Immunocore
Piyush M. Vyas, Ph.D., Senior Research Scientist, Bioassay Development, Eli Lilly and Company
Mingjie Xie, Co-founder and CEO, Rapid Novor Inc
Alexei Yeliseev, Ph.D., Staff Scientist, LMBB, NIH/ NIAAA
Andy Yeung, Ph.D., Associate Research Fellow, Rinat-Pfizer
Travis S. Young, Ph.D., Principal Investigator, Biology, California Institute for Biomedical Research
Ying Qing Yu, Senior Science Manager, Scientific Operations, Waters Corporation
Elsa Wagner-Rousset, Ph.D., Senior Scientist, Analytical Chemistry & Mass Spectrometry, Pierre Fabre
Steven Walfish, Ph.D., Principal Science & Standards Liaison, USP
Jieyi Wang, Ph.D., CEO, Lyvgen Biopharma
Stefan Weigand, Ph.D., Head, Large Molecule Research, Roche Pharma Research and Early Development (pRED), F. Hoffmann-La Roche, Ltd.
Yingxia Wen, Ph.D., Director, Head, Protein Chemistry, Seqirus
Maria Wendt, Ph.D., Head of Science, Biologics, Genedata
Damien B. Wilburn, Ph.D. Post-Doctoral Senior Researcher, Genome Sciences, University of Washington
Ruud de Wildt, Ph.D., Director, Head, Antibody Selections, Biopharm, GlaxoSmithKline
David Winarta, Research Scientist, Global Protein Sciences, AbbVie
Seung-Wuk Lee, Ph.D., Professor, Bioengineering, University of California, Berkeley; Faculty Scientist, Biological Systems and Engineering, Lawrence Berkeley National Laboratory
David D. Weis, Ph.D., Associate Professor, Pharmaceutical Chemistry, University of Kansas
Gregory A. Weiss, Ph.D., Professor, Chemistry, Molecular Biology & Biochemistry, University of California, Irvine
Kipp A. Weiskopf, Ph.D., Research Scientist, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
K. Dane Wittrup, Ph.D., J.R. Mares Professor, Chemical Engineering & Bioengineering, Massachusetts Institute of Technology
Martin Wright, Ph.D., Associate Director, Selection Technologies, Bristol-Myers Squibb
Herren Wu, Ph.D., Senior Vice President, CTO, MedImmune, LLC.
William C. Zamboni, Pharm.D., Ph.D., Associate Professor; Director, TOND2I Lab, University of North Carolina at Chapel Hill
Lan Zhang, Ph.D., Infectious Diseases and Vaccines Discovery, MRL, Merck & Co., Inc.
Min Zhang, Ph.D., Director, Manufacturing Sciences and Technology, AstraZeneca/MedImmune
Eunice Zhou, Ph.D., Associate Adjunct Professor, Anesthesia, University of California, San Francisco
Linglong Zou, Ph.D., Director of Experimental Immunology, Biologics Assays and Technology, Teva
Zhenping Zhu, M.D., Ph.D., Executive Vice President, Biologics, Kadmon Corporation, LLC